ARCHIVES

Radium-233 Dichloride Increased Overall Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Drug Development: Herceptin Associated with 15 Deaths, Genentech Says

May 12, 2000

Women’s Health Study To Supplant Need for WHT, Greenwald Says

May 31, 1991

Science Policcy: HHS Concludes NIH May und Human Stem Cell REsearch

January 22, 1999

Rep. Bliley Challenges FDA On Failure To Approve Oral Colon Cancer Drug UFT.

April 21, 2000

DCPC Board approves 7 New RFAs, 2 Pas

October 21, 1994

AACR To Hold Separate Annual Meeting, Seeks ‘More Meaningful’ Interaction With Clinicians

May 29, 1992